Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.31
-2.12%
Mkt Cap $434.87M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
Implied Upside
+138.1%
Consensus $5.50 vs current $2.31
NASDAQ·Healthcare·Biotechnology
$2.31
-2.12%
Mkt Cap $434.87M
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
+138.1%
Consensus $5.50 vs current $2.31